148 related articles for article (PubMed ID: 10232345)
1. Community-acquired pneumonia.
Holmes A; Jacklin A; Impallomeni M; Rogers TR
Lancet; 1999 May; 353(9163):1528-9. PubMed ID: 10232345
[No Abstract] [Full Text] [Related]
2. [New quinolones for the treatment of community-acquired pneumonia--contra].
Egger M
Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860
[No Abstract] [Full Text] [Related]
3. Antimicrobial resistance in Streptococcus pneumoniae: implications for patients with community-acquired pneumonia.
Chenoweth CE; Saint S; Martinez F; Lynch JP; Fendrick AM
Mayo Clin Proc; 2000 Nov; 75(11):1161-8. PubMed ID: 11075746
[TBL] [Abstract][Full Text] [Related]
4. Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies.
Aubier M; Lode H; Gialdroni-Grassi G; Huchon G; Hosie J; Legakis N; Regamey C; Segev S; Vester R; Wijnands WJ; Tolstuchow N
J Antimicrob Chemother; 1996 May; 37 Suppl A():73-82. PubMed ID: 8737127
[TBL] [Abstract][Full Text] [Related]
5. Therapy for severe community-acquired pneumonia.
Berk SL
Clin Infect Dis; 1997 Jul; 25(1):168-9. PubMed ID: 9243063
[No Abstract] [Full Text] [Related]
6. [New quinolones for the treatment of community-acquired pneumonia--pro].
Zimmerli S
Dtsch Med Wochenschr; 2003 May; 128(19):1070. PubMed ID: 12736859
[No Abstract] [Full Text] [Related]
7. Antibiotic therapy for community-acquired pneumonia.
Mandell LA
Clin Chest Med; 1999 Sep; 20(3):589-98, ix. PubMed ID: 10516906
[TBL] [Abstract][Full Text] [Related]
8. Aetiology and resistance patterns of community-acquired pneumonia in León, Nicaragua.
Matute AJ; Brouwer WP; Hak E; Delgado E; Alonso E; Hoepelman IM
Int J Antimicrob Agents; 2006 Nov; 28(5):423-7. PubMed ID: 17046211
[TBL] [Abstract][Full Text] [Related]
9. [Empirical antibacterial therapy of community acquired pneumonia in outpatients].
Yakovlev SV; Suvorova MP
Antibiot Khimioter; 1997; 42(10):23-8. PubMed ID: 9412399
[No Abstract] [Full Text] [Related]
10. Pneumonia in children.
Berti I; Faraguna D
N Engl J Med; 2002 Jun; 346(24):1916; author reply 1916. PubMed ID: 12063383
[No Abstract] [Full Text] [Related]
11. Treating paediatric community-acquired pneumonia in the era of antimicrobial resistance.
Galli L; Montagnani C; Chiappini E; de Martino M
Acta Paediatr; 2013 Dec; 102(465):25-33. PubMed ID: 24330270
[TBL] [Abstract][Full Text] [Related]
12. [The role of quinolones in the treatment of community acquired pneumonia].
Garau J
Med Clin (Barc); 1998 Feb; 110 Suppl 1():31-5. PubMed ID: 9717158
[No Abstract] [Full Text] [Related]
13. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.
Rosón B; Carratalà J; Tubau F; Dorca J; Liñares J; Pallares R; Manresa F; Gudiol F
Microb Drug Resist; 2001; 7(1):85-96. PubMed ID: 11310807
[TBL] [Abstract][Full Text] [Related]
14. Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy.
Donald BJ; Surani S; Deol HS; Mbadugha UJ; Udeani G
Drug Des Devel Ther; 2017; 11():3559-3566. PubMed ID: 29263651
[TBL] [Abstract][Full Text] [Related]
15. Doxycycline for nursing home acquired pneumonia (NHAP).
Cunha BA
Scand J Infect Dis; 2009; 41(1):77-8, author reply 76. PubMed ID: 18821134
[No Abstract] [Full Text] [Related]
16. Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia.
Lynch III JP; Martinez FJ
Clin Infect Dis; 2002 Mar; 34 Suppl 1():S27-46. PubMed ID: 11810608
[TBL] [Abstract][Full Text] [Related]
17. Novel agents for the treatment of outpatient respiratory tract infections. Introduction.
Pell DM
Postgrad Med; 2002 Sep; 112(3 Suppl):5-6. PubMed ID: 19667592
[No Abstract] [Full Text] [Related]
18. [Antibiotic resistance of S. pneumoniae and H. influenzae strains isolated from patients with community acquired respiratory tract infections. BACTRO multicenter, multidisciplinary study].
Tudose C; Bumbăcea D; Bogdan M;
Pneumologia; 2011; 60(1):30-5. PubMed ID: 21548198
[TBL] [Abstract][Full Text] [Related]
19. Community-acquired pneumonia in Ugandan adults: short-term parenteral ampicillin therapy for bacterial pneumonia.
Yoshimine H; Oishi K; Mubiru F; Nalwoga H; Takahashi H; Amano H; Ombasi P; Watanabe K; Joloba M; Aisu T; Ahmed K; Shimada M; Mugerwa R; Nagatake T
Am J Trop Med Hyg; 2001; 64(3-4):172-7. PubMed ID: 11442214
[TBL] [Abstract][Full Text] [Related]
20. Empirical therapy of community-acquired pneumonia: macrolides are not ideal choices.
Bartlett JG
Semin Respir Infect; 1997 Dec; 12(4):329-33. PubMed ID: 9436960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
